Quizartinib is a small molecule receptor tyrosine kinase inhibitor.
Quizartinib selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3, colony-stimulating factor 1 receptor, stem cell factor receptor, and platelet derived growth factor receptors.

Market Analysis and Insights: Global Quizartinib Market
In 2020, the global Quizartinib market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Quizartinib Scope and Market Size
The global Quizartinib market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Quizartinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Solution
Powder

Segment by Application
Research Laboratory
Hospital
Others

By Company
AdipoGen Life Sciences, Inc.
APExBIO Technology LLC
Biorbyt Ltd.
BioVision，Inc.
Cayman Chemical Company
Enzo Biochem Inc.
MedChemExpress (MCE)
Selleck Chemicals
Target Molecule Corp.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE